{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:11:39Z","timestamp":1791299499353,"version":"4.1.0"},"reference-count":95,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2,1]]},"abstract":"<jats:p>The islet in type 2 diabetes (T2DM) is characterized by a deficit in \u03b2-cells, increased \u03b2-cell apoptosis, and extracellular amyloid deposits derived from islet amyloid polypeptide (IAPP). In the absence of longitudinal studies, it is unknown if the low \u03b2-cell mass in T2DM precedes diabetes onset (is a risk factor for diabetes) or develops as a consequence of the disease process. Although insulin resistance is a risk factor for T2DM, most individuals who are insulin resistant do not develop diabetes. By inference, an increased \u03b2-cell workload results in T2DM in some but not all individuals. We propose that the extent of the \u03b2-cell mass that develops during childhood may underlie subsequent successful or failed adaptation to insulin resistance in later life. We propose that a low innate \u03b2-cell mass in the face of subsequent insulin resistance may expose \u03b2-cells to a burden of insulin and IAPP biosynthetic demand that exceeds the cellular capacity for protein folding and trafficking. If this threshold is crossed, intracellular toxic IAPP membrane permeant oligomers (cylindrins) may form, compromising \u03b2-cell function and inducing \u03b2-cell apoptosis.<\/jats:p>","DOI":"10.2337\/db12-1326","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T23:59:41Z","timestamp":1359071981000},"page":"327-335","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":110,"title":["\u03b2-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?"],"prefix":"10.2337","volume":"62","author":[{"given":"Safia","family":"Costes","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Langen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Keck School of Medicine, Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Gurlo","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey V.","family":"Matveyenko","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Larry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,1,17]]},"reference":[{"key":"2022031210124982600_B1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"2022031210124982600_B2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","article-title":"Pancreatic beta-cell mass in European subjects with type 2 diabetes","volume":"10","author":"Rahier","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"2022031210124982600_B3","first-page":"110","article-title":"Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited","volume":"4","author":"Kl\u00f6ppel","year":"1985","journal-title":"Surv Synth Pathol Res"},{"key":"2022031210124982600_B4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(87)90825-7","article-title":"Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes","volume":"2","author":"Clark","year":"1987","journal-title":"Lancet"},{"key":"2022031210124982600_B5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"2022031210124982600_B6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo","year":"1994","journal-title":"Nature"},{"key":"2022031210124982600_B7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"2022031210124982600_B8","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"2022031210124982600_B9","doi-asserted-by":"crossref","first-page":"26482","DOI":"10.1074\/jbc.271.43.26482","article-title":"Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity","volume":"271","author":"McLaurin","year":"1996","journal-title":"J Biol Chem"},{"key":"2022031210124982600_B10","first-page":"772","article-title":"Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus","volume":"232","author":"Hayden","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"2022031210124982600_B11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr Rev"},{"key":"2022031210124982600_B12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"2022031210124982600_B13","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmb.2003.11.048","article-title":"Structural characterisation of islet amyloid polypeptide fibrils","volume":"335","author":"Sumner Makin","year":"2004","journal-title":"J Mol Biol"},{"key":"2022031210124982600_B14","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","article-title":"Fibril structure of human islet amyloid polypeptide","volume":"287","author":"Bedrood","year":"2012","journal-title":"J Biol Chem"},{"key":"2022031210124982600_B15","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","article-title":"Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR","volume":"46","author":"Luca","year":"2007","journal-title":"Biochemistry"},{"key":"2022031210124982600_B16","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1110\/ps.036509.108","article-title":"Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin)","volume":"17","author":"Wiltzius","year":"2008","journal-title":"Protein Sci"},{"key":"2022031210124982600_B17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/jsbi.1997.3858","article-title":"Polymorphic fibrillar assembly of human amylin","volume":"119","author":"Goldsbury","year":"1997","journal-title":"J Struct Biol"},{"key":"2022031210124982600_B18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0033583508004733","article-title":"Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy","volume":"41","author":"Margittai","year":"2008","journal-title":"Q Rev Biophys"},{"key":"2022031210124982600_B19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","article-title":"Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships","volume":"19","author":"Bemporad","year":"2012","journal-title":"Chem Biol"},{"key":"2022031210124982600_B20","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J Biol Chem"},{"key":"2022031210124982600_B21","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1111\/j.1742-4658.2010.07889.x","article-title":"Biochemical and biophysical features of both oligomer\/fibril and cell membrane in amyloid cytotoxicity","volume":"277","author":"Stefani","year":"2010","journal-title":"FEBS J"},{"key":"2022031210124982600_B22","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer\u2019s-related amyloid beta oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J Neurosci"},{"key":"2022031210124982600_B23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2006.04157.x","article-title":"Monoclonal antibodies that target pathological assemblies of Abeta","volume":"100","author":"Lambert","year":"2007","journal-title":"J Neurochem"},{"key":"2022031210124982600_B24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"2022031210124982600_B25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1213151","article-title":"Atomic view of a toxic amyloid small oligomer","volume":"335","author":"Laganowsky","year":"2012","journal-title":"Science"},{"key":"2022031210124982600_B26"},{"key":"2022031210124982600_B27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","article-title":"Phospholipid catalysis of diabetic amyloid assembly","volume":"341","author":"Knight","year":"2004","journal-title":"J Mol Biol"},{"key":"2022031210124982600_B28","doi-asserted-by":"crossref","first-page":"12113","DOI":"10.1021\/bi050840w","article-title":"Lipid membranes modulate the structure of islet amyloid polypeptide","volume":"44","author":"Jayasinghe","year":"2005","journal-title":"Biochemistry"},{"key":"2022031210124982600_B29","doi-asserted-by":"crossref","first-page":"17205","DOI":"10.1074\/jbc.M801383200","article-title":"Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding","volume":"283","author":"Apostolidou","year":"2008","journal-title":"J Biol Chem"},{"key":"2022031210124982600_B30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1210\/jcem-51-3-520","article-title":"Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior","volume":"51","author":"Eaton","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210124982600_B31","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI111601","article-title":"C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog","volume":"74","author":"Polonsky","year":"1984","journal-title":"J Clin Invest"},{"key":"2022031210124982600_B32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00500385","article-title":"Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Sanke","year":"1991","journal-title":"Diabetologia"},{"key":"2022031210124982600_B33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(95)01460-8","article-title":"Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2","volume":"378","author":"Badman","year":"1996","journal-title":"FEBS Lett"},{"key":"2022031210124982600_B34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev-biochem-072909-095555","article-title":"Endoplasmic reticulum stress and type 2 diabetes","volume":"81","author":"Back","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"2022031210124982600_B35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1463-1326.2010.01271.x","article-title":"The endoplasmic reticulum stress response in the pancreatic \u03b2-cell","volume":"12","author":"Volchuk","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"2022031210124982600_B36","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/ja1007867","article-title":"Role of zinc in human islet amyloid polypeptide aggregation","volume":"132","author":"Brender","year":"2010","journal-title":"J Am Chem Soc"},{"key":"2022031210124982600_B37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ar200189b","article-title":"Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective","volume":"45","author":"Brender","year":"2012","journal-title":"Acc Chem Res"},{"key":"2022031210124982600_B38","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1021\/bi00044a038","article-title":"Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro","volume":"34","author":"Charg\u00e9","year":"1995","journal-title":"Biochemistry"},{"key":"2022031210124982600_B39","doi-asserted-by":"crossref","first-page":"15598","DOI":"10.1021\/ja205007j","article-title":"Low pH acts as inhibitor of membrane damage induced by human islet amyloid polypeptide","volume":"133","author":"Khemt\u00e9mourian","year":"2011","journal-title":"J Am Chem Soc"},{"key":"2022031210124982600_B40","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/bi901076d","article-title":"Impaired processing of human pro-islet amyloid polypeptide is not a causative factor for fibril formation or membrane damage in vitro","volume":"48","author":"Khemt\u00e9mourian","year":"2009","journal-title":"Biochemistry"},{"key":"2022031210124982600_B41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3310809","article-title":"A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation","volume":"331","author":"Kudva","year":"1998","journal-title":"Biochem J"},{"key":"2022031210124982600_B42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/pr800675k","article-title":"Proteins associated with immunopurified granules from a model pancreatic islet beta-cell system: proteomic snapshot of an endocrine secretory granule","volume":"8","author":"Hickey","year":"2009","journal-title":"J Proteome Res"},{"key":"2022031210124982600_B43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/BJ20100434","article-title":"The chaperone proteins HSP70, HSP40\/DnaJ and GRP78\/BiP suppress misfolding and formation of \u03b2-sheet-containing aggregates by human amylin: a potential role for defective chaperone biology in Type\u00a02 diabetes","volume":"432","author":"Chien","year":"2010","journal-title":"Biochem J"},{"key":"2022031210124982600_B44","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1209235","article-title":"Road to ruin: targeting proteins for degradation in the endoplasmic reticulum","volume":"334","author":"Smith","year":"2011","journal-title":"Science"},{"key":"2022031210124982600_B45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2022031210124982600_B46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","article-title":"Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy","volume":"11","author":"Ravikumar","year":"2002","journal-title":"Hum Mol Genet"},{"key":"2022031210124982600_B47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2009.04.026","article-title":"A role for ubiquitin in selective autophagy","volume":"34","author":"Kirkin","year":"2009","journal-title":"Mol Cell"},{"key":"2022031210124982600_B48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cmet.2008.08.009","article-title":"Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet","volume":"8","author":"Ebato","year":"2008","journal-title":"Cell Metab"},{"key":"2022031210124982600_B49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/cdd.2010.111","article-title":"Human-IAPP disrupts the autophagy\/lysosomal pathway in pancreatic \u03b2-cells: protective role of p62-positive cytoplasmic inclusions","volume":"18","author":"Rivera","year":"2011","journal-title":"Cell Death Differ"},{"key":"2022031210124982600_B50","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am J Pathol"},{"key":"2022031210124982600_B51","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1242\/jcs.019265","article-title":"Autophagy, amyloidogenesis and Alzheimer disease","volume":"120","author":"Nixon","year":"2007","journal-title":"J Cell Sci"},{"key":"2022031210124982600_B52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","article-title":"The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation","volume":"53","author":"Cnop","year":"2010","journal-title":"Diabetologia"},{"key":"2022031210124982600_B53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1074\/jbc.M109.024190","article-title":"Calcium-activated calpain-2 is a mediator of beta cell dysfunction and apoptosis in type 2 diabetes","volume":"285","author":"Huang","year":"2010","journal-title":"J Biol Chem"},{"key":"2022031210124982600_B54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ilar.47.3.225","article-title":"Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes","volume":"47","author":"Matveyenko","year":"2006","journal-title":"ILAR J"},{"key":"2022031210124982600_B55","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031210124982600_B56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2337\/diab.45.8.1094","article-title":"Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and beta-cell dysfunction","volume":"45","author":"Couce","year":"1996","journal-title":"Diabetes"},{"key":"2022031210124982600_B57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.47.5.743","article-title":"Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide","volume":"47","author":"Soeller","year":"1998","journal-title":"Diabetes"},{"key":"2022031210124982600_B58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/db10-0522","article-title":"\u03b2-cell dysfunctional ERAD\/ubiquitin\/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency","volume":"60","author":"Costes","year":"2011","journal-title":"Diabetes"},{"key":"2022031210124982600_B59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00410276","article-title":"Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment","volume":"38","author":"Mulder","year":"1995","journal-title":"Diabetologia"},{"key":"2022031210124982600_B60","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2337\/db07-1369","article-title":"Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans","volume":"57","author":"Meier","year":"2008","journal-title":"Diabetes"},{"key":"2022031210124982600_B61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diacare.29.03.06.dc05-1538","article-title":"Relationship between beta-cell mass and fasting blood glucose concentration in humans","volume":"29","author":"Ritzel","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031210124982600_B62","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.2337\/diabetes.50.9.2001","article-title":"Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig","volume":"50","author":"Kjems","year":"2001","journal-title":"Diabetes"},{"key":"2022031210124982600_B63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00125-009-1552-z","article-title":"Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys","volume":"53","author":"Saisho","year":"2010","journal-title":"Diabetologia"},{"key":"2022031210124982600_B64","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/db05-1672","article-title":"Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes","volume":"55","author":"Matveyenko","year":"2006","journal-title":"Diabetes"},{"key":"2022031210124982600_B65","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1210\/en.2010-0978","article-title":"Differential effects of prenatal and postnatal nutritional environment on \u03b2-cell mass development and turnover in male and female rats","volume":"151","author":"Matveyenko","year":"2010","journal-title":"Endocrinology"},{"key":"2022031210124982600_B66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MCO.0b013e328351f543","article-title":"Genetic origins of low birth weight","volume":"15","author":"Yaghootkar","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2022031210124982600_B67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jcem-72-2-277","article-title":"Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism","volume":"72","author":"Amiel","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210124982600_B68","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"2022031210124982600_B69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/diacare.22.5.773","article-title":"Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry","volume":"22","author":"Berger","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031210124982600_B70","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diabetes.52.7.1738","article-title":"Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance","volume":"52","author":"Basu","year":"2003","journal-title":"Diabetes"},{"key":"2022031210124982600_B71","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.exger.2010.03.018","article-title":"Impaired quality control of mitochondria: aging from a new perspective","volume":"45","author":"Weber","year":"2010","journal-title":"Exp Gerontol"},{"key":"2022031210124982600_B72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.arr.2010.02.001","article-title":"Protein homeostasis and aging: The importance of exquisite quality control","volume":"10","author":"Koga","year":"2011","journal-title":"Ageing Res Rev"},{"key":"2022031210124982600_B73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nbd.2006.02.012","article-title":"Inhibitory effects of pesticides on proteasome activity: implication in Parkinson\u2019s disease","volume":"23","author":"Wang","year":"2006","journal-title":"Neurobiol Dis"},{"key":"2022031210124982600_B74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/auto.1.3.2017","article-title":"Autophagy and aging: the importance of maintaining \u201cclean\u201d cells","volume":"1","author":"Cuervo","year":"2005","journal-title":"Autophagy"},{"key":"2022031210124982600_B75","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000213753","article-title":"The effect of age on formation and elimination of autophagic vacuoles in mouse hepatocytes","volume":"41","author":"Terman","year":"1995","journal-title":"Gerontology"},{"key":"2022031210124982600_B76","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","article-title":"Neurodegenerative lysosomal disorders: a continuum from development to late age","volume":"4","author":"Nixon","year":"2008","journal-title":"Autophagy"},{"key":"2022031210124982600_B77","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"2022031210124982600_B78","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00125-009-1347-2","article-title":"Autophagy in human type 2 diabetes pancreatic beta cells","volume":"52","author":"Masini","year":"2009","journal-title":"Diabetologia"},{"key":"2022031210124982600_B79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.molmed.2010.06.004","article-title":"The emerging genetics of type 2 diabetes","volume":"16","author":"Bonnefond","year":"2010","journal-title":"Trends Mol Med"},{"key":"2022031210124982600_B80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ng.120","article-title":"Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes","volume":"40","author":"Zeggini","year":"2008","journal-title":"Nat Genet"},{"key":"2022031210124982600_B81","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1172\/JCI39678","article-title":"Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells","volume":"120","author":"Fonseca","year":"2010","journal-title":"J Clin Invest"},{"key":"2022031210124982600_B82","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/hmg\/ddq568","article-title":"Wolfram syndrome 1 gene (WFS1) product localizes to secretory granules and determines granule acidification in pancreatic beta-cells","volume":"20","author":"Hatanaka","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2022031210124982600_B83","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","article-title":"An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures","volume":"52","author":"Bennett","year":"2003","journal-title":"Diabetes"},{"key":"2022031210124982600_B84","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s001250100531","article-title":"S20G mutation of the amylin gene is associated with Type II diabetes in Japanese","volume":"44","author":"Seino","year":"2001","journal-title":"Diabetologia"},{"key":"2022031210124982600_B85","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/13506120108993820","article-title":"Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide","volume":"8","author":"Ma","year":"2001","journal-title":"Amyloid"},{"key":"2022031210124982600_B86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/diab.39.3.283","article-title":"Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution","volume":"39","author":"Haffner","year":"1990","journal-title":"Diabetes"},{"key":"2022031210124982600_B87","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","article-title":"Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death","volume":"55","author":"Marzban","year":"2006","journal-title":"Diabetes"},{"key":"2022031210124982600_B88","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"2022031210124982600_B89","doi-asserted-by":"crossref","first-page":"E1656","DOI":"10.1152\/ajpendo.00318.2007","article-title":"Induction of endoplasmic reticulum stress-induced beta-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide","volume":"293","author":"Huang","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210124982600_B90","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)65360-6","article-title":"Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells","volume":"154","author":"Hiddinga","year":"1999","journal-title":"Am J Pathol"},{"key":"2022031210124982600_B91","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1007\/s00125-009-1329-4","article-title":"Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress","volume":"52","author":"Hull","year":"2009","journal-title":"Diabetologia"},{"key":"2022031210124982600_B92","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"\u03b2-cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am J Pathol"},{"key":"2022031210124982600_B93","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00400722","article-title":"Rapid deposition of amyloid in human islets transplanted into nude mice","volume":"38","author":"Westermark","year":"1995","journal-title":"Diabetologia"},{"key":"2022031210124982600_B94","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2337\/diab.26.3.201","article-title":"A morphologic study of intrahepatic portal-vein islet isografts","volume":"26","author":"Griffith","year":"1977","journal-title":"Diabetes"},{"key":"2022031210124982600_B95","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/2\/327\/571727\/327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/2\/327\/571727\/327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:33:57Z","timestamp":1667406837000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/2\/327\/15495\/Cell-Failure-in-Type-2-Diabetes-A-Case-of-Asking"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,17]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,1,17]]},"published-print":{"date-parts":[[2013,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db12-1326","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,17]]}}}